Using micrograms of two medicines, injected into mice, scientists saw cancerous tumors disappear. Lenox Hill Hospital head of Urology, Dr. David Samadi has written about this technique in a previous article, “Re-programming Your Body To Fight Cancer.” 90 mice were tested, and Standford University researchers say human clinical trials should begin by end of year.
This could be a quick and relatively inexpensive strategy, less expensive and with fewer side effects than other immunotherapies available today. The strategy developed aims to reactivate the ability of the immune system to recognize and destroy cancer cells. Dr. Samadi says this will be a pioneer in the field of immunotherapy.
The two medicines have two different functions: one is an amplifier of a particular receptor (OX40), which is present on the T cells of the immune system, while the second one binds to this receptor and guides against cancer.The mix worked well in laboratory mice with lymphoma that had the tumor transplanted into two distinct parts of the body. 87 out of 90 mice were healed from cancer. The researchers observed similar results in mice with breast, colon and cutaneous melanoma tumors.
According to Dr. David Samadi, these new immunotherapies are encouraging. This particular approach ignores the need to identify the tumor’s specific immune targets and does not require the general activation of the whole immune system. Hopefully, in the future, there won’t be a limit on the types of cancers that are treatable using this approach, added Dr. Samadi.
What Is Immunotherapy?
It’s a relatively new effective weapon to fight cancer and lengthen the long-term survival of patients. This technique aims at restoring the immune system using antibodies that “reactivate traffic lights” blocked by the tumor, so that the body can again attack the diseased cells. Continuation of clinical trials may result in a relatively inexpensive strategy at beating cancer says Dr. Samadi.
Dr. David Samadi specializes in urologic diseases, and is internationally known for his Samadi Modified Advanced Robotic Technique (SMART surgery). Dr. Samadii customized a prostate surgery procedure, resulting in a less invasive technique that cut down the surgery time, as well as the patient’s recovery time. This particular surgery protects the surrounding nerve bundles and Dr. Samadi has performed over 7,000 surgeries, domestically and internationally.
Dr. Samadi holds multiple “America’s Top Doctor” and “America’s Top Doctor for Cancer” awards, and was named “Best Doctor” for five consecutive years, and “Most Compassionate Doctor” from 2010 to 2013. In addition to his work at Lenox Hill Hospital, he is a medical correspondent for Fox News, and has his own show, Sunday Housecall, that airs on Sundays at 12:30pm.
For details: prostatecancer911.com/david-samadi/